Science 37 was the top enrolling site, contributing 77% of all study participants. Compared with 14 participants across four traditional brick-and-mortar sites combined, Science 37 enrolled 46 participants as a single site and achieved 115% of its original enrollment target. Its Direct-to-Patient Site model also supported 98% participant retention, with 45 of 46 participants completing the study.
